Spyre Therapeutics Appoints Cameron Turtle DPhil as Chief Executive Officer
Position
Chief Executive Officer
Company
Spyre Therapeutics
WalthamBiotechnologyHealth CareTherapeuticsDescription
Spyre Therapeutics announces the appointment of Cameron Turtle DPhil as Chief Executive Officer, the initiation of trading on the Nasdaq, and encouraging updates on its investigational antibody therapeutics targeting inflammatory bowel disease (IBD). The company also raised a substantial $180 million through private placement equity financing to advance its promising drug candidates, SPY001 and SPY002.
Quick answer
Spyre Therapeutics Appoints Cameron Turtle DPhil as Chief Executive Officer (March 1, 2024). Spyre Therapeutics is based in Waltham, Massachusetts, United States.
- Who is the new Chief Executive Officer at Spyre Therapeutics?
- Spyre Therapeutics named Cameron Turtle Chief Executive Officer, announced March 1, 2024.
- What did Spyre Therapeutics announce on March 1, 2024?
- Spyre Therapeutics announces the appointment of Cameron Turtle DPhil as Chief Executive Officer, the initiation of trading on the Nasdaq, and encouraging updates on its investigational antibody therapeutics targeting inflammatory bowel disease (IBD). The company also raised a substantial $180 million through private placement equity financing to advance its promising drug candidates, SPY001 and SPY002.
- What does Spyre Therapeutics do?
- Spyre Therapeutics is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and rheumatic diseases.
- Where is Spyre Therapeutics based?
- Spyre Therapeutics is based in Waltham, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- OncoNano Medicine (March 1, 2024), Corbus Pharmaceuticals Holdings (March 1, 2024), Bexion Pharmaceuticals (March 2, 2024) and Rapport (February 28, 2024) also announced leadership changes within 45 days of Spyre Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- OncoNano Medicine Appoints Dr. Kartik Krishnan as Chief Executive Officer and Dr. Melissa Paoloni as Executive Vice President and Chief Operating Officer (March 1, 2024)
- Corbus Pharmaceuticals Appoints Dominic Smethurst as Chief Medical Officer (March 1, 2024)
- Bexion Pharmaceuticals, Inc. Appoints Tariq Arshad as Chief Medical Officer (March 2, 2024)
- Rapport Therapeutics Appoints Kathy Wilkinson as Chief People Officer (February 28, 2024)
- Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer (February 28, 2024)
- Madrigal Pharmaceuticals Appoints Mardi C. Dier as Chief Financial Officer (February 28, 2024)
Who to call at Spyre Therapeutics, and when
A new leader at Spyre Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Spyre Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Spyre Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Spyre Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Spyre Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Spyre Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.